Wisdom Pharmaceuticals: Announcement on the Company\'s Completion of the Registration of Industrial and Commercial Changes
Wisdom Pharmaceutical: Wisdom Pharmaceutical Technology Co., Ltd. plans to implement the asset evaluation report for all shareholders\' equity value projects involved in the management takeover
Wisdom Pharmaceutical: Report of the board of directors of Wisdom Pharmaceutical Technology Co., Ltd. to all shareholders on the company\'s management takeover
Smart Medicine: Announcement of Resolutions of the Fourth Meeting of the 6th Board of Directors
Smart Medicine: Announcement of Resolutions of the Fourth Meeting of the 6th Board of Supervisors
Wisdom Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Wisdom Pharmaceuticals: Independent Financial Advisory Report of Beijing Bossing Securities Investment Advisory Co., Ltd. on the management takeover of Wisdom Pharmaceutical Technology Co., Ltd.
Wisdom Pharmaceutical: Announcement of Resolutions of the Third Extraordinary General Meeting of Shareholders in 2024
Wisdom Pharmaceuticals: Legal Opinion of the Third Extraordinary General Meeting of Shareholders in 2024
Wisdom Pharmaceutical: Announcement on the progress of foreign investment of wholly-owned subsidiaries
Smart Pharmaceuticals: Written review opinions of the company\'s supervisory board on matters relating to the company\'s issuance of shares to specific targets
Smart Pharmaceuticals: 2024 Stock Issuance Plan to Specific Targets
Wisdom Pharmaceutical: Announcement on holding a shareholders\' meeting at an optional date
Smart Medicine: Announcement of Resolutions of the Third Meeting of the 6th Board of Directors
Smart Pharmaceuticals: Announcement on signing conditionally effective share subscription agreements and related transactions with specific targets
Wisdom Pharmaceuticals: Announcement on the progress of lawsuits involving the company\'s controlling shareholders and chairman
Smart Pharmaceuticals: Simplified Equity Change Report
Smart Pharmaceuticals: An Empirical Analysis Report on the 2024 Stock Issuance Plan to Specific Targets
Smart Pharmaceuticals: Announcement on the impact of issuing stocks to specific targets in 2024, diluted spot returns, measures to fill returns, and commitments from related entities
Smart Pharmaceuticals: Announcement on the need to prepare a report on the use of funds raised previously